Trimebutine

Trimebutine

SCHEMBL2017641

CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C.CNCCc1ccccn1.O=C(O)/C=C\C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1HRH3

The experimentally established mechanism targets of Trimebutine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 known ✓ Q9Y5N1 1/20 0.37
ALDH1A1 P00352 6/20 0.74
LMNA P02545 3/20 0.74
MAPT P10636 3/20 0.74
OPRM1 P35372 2/20 0.74
OPRD1 P41143 2/20 0.74
MAPK1 P28482 2/20 0.74
SMN1; SMN2 Q16637 2/20 0.74
MEN1 O00255 1/20 0.74
CYP3A4 P08684 1/20 0.74
KMT2A Q03164 1/20 0.74
HIF1A Q16665 1/20 0.74
NR1I2 O75469 1/20 0.66
CHRM2 P08172 1/20 0.66
ADORA3 P0DMS8 1/20 0.66
ADRA2B P18089 1/20 0.66
SLC6A4 P31645 1/20 0.66
OPRK1 P41145 1/20 0.66
CHRNA4 P43681 1/20 0.66
SLC6A3 Q01959 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimebutine SCHEMBL1652810 0.86 ALDH1A1 (1.00) ALDH1A1LMNAMAPTOPRM1OPRD1
Trimebutine SCHEMBL67225 0.86 ALDH1A1 (1.00) ALDH1A1LMNAMAPTOPRM1OPRD1
Trimebutine SCHEMBL28274910 0.86 ALDH1A1 (1.00) ALDH1A1LMNAMAPTOPRM1OPRD1
Trimebutine SCHEMBL5011979 0.86 ALDH1A1 (1.00) ALDH1A1LMNAMAPTOPRM1OPRD1
Trimebutine SCHEMBL14273976 0.81 OPRM1 (1.00) ALDH1A1LMNAMAPTOPRM1OPRD1
Trimebutine SCHEMBL25705 0.81 OPRM1 (1.00) ALDH1A1LMNAMAPTOPRM1OPRD1
Trimebutine SCHEMBL7428847 0.80 OPRM1 (0.98) ALDH1A1LMNAMAPTOPRM1OPRD1
SCHEMBL16522145 0.76 OPRM1 (0.88) ALDH1A1LMNAMAPTOPRM1OPRD1
SCHEMBL14317655 0.74 OPRM1 (0.83) ALDH1A1LMNAMAPTOPRM1OPRD1
Maleic Acid SCHEMBL6116431 0.73 KMT2A (0.68) ALDH1A1LMNAMAPTOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152161-A1 COMPOSITIONS FOR WEIGHT MANAGEMENT MOR RESEARCH APPLICATIONS LTD. (IL) 2010-06-17 US claimed
US-7737165-B2 Methods of reducing weight gain associated with olanzapine treatment MOR RESEARCH APPLICATIONS LTD. (IL) 2010-06-15 US claimed
US-7728015-B2 Compositions for weight management MOR RESEARCH APPLICATIONS LTD. (IL) 2010-06-01 US claimed
US-20080051440-A1 Compositions for weight management MOR RESEARCH APPLICATIONS LTD. (IL) 2008-02-28 US claimed
US-20080051439-A1 Methods of food intake management MOR RESEARCH APPLICATIONS LTD. (IL) 2008-02-28 US claimed
US-20080004324-A1 Methods of preventing weight gain MOR RESEARCH APPLICATIONS LTD. (IL) 2008-01-03 US claimed
US-20080003306-A1 Compositions for weight management MOR RESEARCH APPLICATIONS LTD. (IL) 2008-01-03 US claimed
US-20080004322-A1 Methods of food intake management MOR RESEARCH APPLICATIONS LTD. (IL) 2008-01-03 US claimed
US-20080004254-A1 Compositions for weight management MOR RESEARCH APPLICATIONS LTD. (IL) 2008-01-03 US claimed
EP-1737454-A4 METHOD OF FOOD INTAKE MANAGEMENT MOR RESEARCH APPLIC LTD (IL) 2007-08-08 EP claimed
CN-1933835-A Methods of preventing weight gain MOR RESEARCH APPLIC LTD (IL) 2007-03-21 CN claimed
EP-1737454-A2 METHOD OF FOOD INTAKE MANAGEMENT MOR RESEARCH APPLICATIONS LTD. (IL) 2007-01-03 EP claimed
US-20060148787-A1 Compositions for weight management MOR RESEARCH APPLICATIONS LTD. 2006-07-06 US claimed
US-20060084686-A1 Methods of food intake management MOR RESEARCH APPLICATIONS LTD. 2006-04-20 US claimed
US-20060073217-A1 Methods of preventing weight gain MOR RESEARCH APPLICATIONS LTD. 2006-04-06 US claimed
WO-2005101979-A2 METHOD OF FOOD INTAKE MANAGEMENT MOR RESEARCH APPLICATIONS LTD. (IL) 2005-11-03 WO claimed
WO-2011073981-A2 COMPOSITIONS AND METHODS FOR TREATING SOMNOLENCE MOR RESEARCH APPLICATIONS LTD. (IL) 2011-06-23 WO disclosed
US-20100152161-A1 COMPOSITIONS FOR WEIGHT MANAGEMENT MOR RESEARCH APPLICATIONS LTD. (IL) 2010-06-17 US disclosed
US-20060073217-A1 Methods of preventing weight gain MOR RESEARCH APPLICATIONS LTD. 2006-04-06 US disclosed
WO-2005101979-A2 METHOD OF FOOD INTAKE MANAGEMENT MOR RESEARCH APPLICATIONS LTD. (IL) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004322-A1 Methods of food intake management HCRTR1, HCRTR2, HRH4 HRH3 4/4885ALDH1A1 1759/4885LMNA 3046/4885
US-20060148787-A1 Compositions for weight management HCRTR1, HCRTR2, GPR119 HRH3 6/4885ALDH1A1 2341/4885LMNA 2417/4885
US-20080003306-A1 Compositions for weight management HCRTR1, HCRTR2, GPR119 HRH3 6/4885ALDH1A1 2341/4885LMNA 2417/4885
US-20080004324-A1 Methods of preventing weight gain GPR119, HRH4, MTNR1A HRH3 6/4885ALDH1A1 725/4885LMNA 1969/4885
US-20080004254-A1 Compositions for weight management HCRTR1, HCRTR2, GPR119 HRH3 6/4885ALDH1A1 2341/4885LMNA 2417/4885
US-20060084686-A1 Methods of food intake management HCRTR1, HCRTR2, HRH4 HRH3 4/4885ALDH1A1 1759/4885LMNA 3046/4885
US-20100152161-A1 COMPOSITIONS FOR WEIGHT MANAGEMENT HNMT, BHMT, HRH4 HRH3 4/4885ALDH1A1 1894/4885LMNA 1486/4885
US-20060073217-A1 Methods of preventing weight gain GPR119, HRH4, MTNR1A HRH3 6/4885ALDH1A1 725/4885LMNA 1969/4885
US-20080051439-A1 Methods of food intake management HCRTR1, HCRTR2, HRH4 HRH3 4/4885ALDH1A1 1759/4885LMNA 3046/4885
US-20080051440-A1 Compositions for weight management HCRTR1, HCRTR2, GPR119 HRH3 6/4885ALDH1A1 2260/4885LMNA 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.